Contribution of Mg supplementation and hight volume hydration to the renal toxicity in patients with lung cancer treated by cisplatin: a historical prospective cohort study.

Contribution of Mg supplementation and hight volume hydration to the renal toxicity in patients with lung cancer treated by cisplatin: a historical prospective cohort study. - An examination of reducing the renal toxicity caused by cisplatin.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013950

Enrollment

Registered

2014-05-13

Start date

2013-10-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer patients treated with cisplatin

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with malignant chest tumors who were receiving their first cycle of cisplatin-based chemotherapy at the Osaka City University Hospital between December 2011 and October 2013.

Exclusion criteria

Exclusion criteria: We excluded four patients whose complications or medical histories may have affected their renal function.

Design outcomes

Primary

Measure	Time frame
delta creatinine, delta creatinine clearance	—

Countries

Japan

Contacts

Public ContactTatsuo Kimura

Graduate school of Medicine, Osaka City University Department of Respiratory Medicine

kimutats@med.osaka-cu.ac.jp81-6-6645-3916

Outcome results